The Food and Drug Administration may soon require drug companies to expand antidepressant warning labels to include increased suicide risk for young adults, according to a plan put forth by FDA officials at an advisory hearing Wednesday.
By PBS NewsHour
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.